156 related articles for article (PubMed ID: 15021899)
1. A link between p73 transcriptional activity and p73 degradation.
Wu L; Zhu H; Nie L; Maki CG
Oncogene; 2004 May; 23(22):4032-6. PubMed ID: 15021899
[TBL] [Abstract][Full Text] [Related]
2. Transactivation-dependent and -independent regulation of p73 stability.
Dulloo I; Sabapathy K
J Biol Chem; 2005 Aug; 280(31):28203-14. PubMed ID: 15919663
[TBL] [Abstract][Full Text] [Related]
3. MDM2 suppresses p73 function without promoting p73 degradation.
Zeng X; Chen L; Jost CA; Maya R; Keller D; Wang X; Kaelin WG; Oren M; Chen J; Lu H
Mol Cell Biol; 1999 May; 19(5):3257-66. PubMed ID: 10207051
[TBL] [Abstract][Full Text] [Related]
4. Functional interplay between MDM2, p63/p73 and mutant p53.
Stindt MH; Muller PA; Ludwig RL; Kehrloesser S; Dötsch V; Vousden KH
Oncogene; 2015 Aug; 34(33):4300-10. PubMed ID: 25417702
[TBL] [Abstract][Full Text] [Related]
5. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
[TBL] [Abstract][Full Text] [Related]
6. p73 transcriptional activity increases upon cooperation between its spliced forms.
Alarcon-Vargas D; Fuchs SY; Deb S; Ronai Z
Oncogene; 2000 Feb; 19(6):831-5. PubMed ID: 10698502
[TBL] [Abstract][Full Text] [Related]
7. A possible role of p73 on the modulation of p53 level through MDM2.
Wang XQ; Ongkeko WM; Lau AW; Leung KM; Poon RY
Cancer Res; 2001 Feb; 61(4):1598-603. PubMed ID: 11245471
[TBL] [Abstract][Full Text] [Related]
8. Mdm2 binds p73 alpha without targeting degradation.
Bálint E; Bates S; Vousden KH
Oncogene; 1999 Jul; 18(27):3923-9. PubMed ID: 10435614
[TBL] [Abstract][Full Text] [Related]
9. p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop.
Kartasheva NN; Contente A; Lenz-Stöppler C; Roth J; Dobbelstein M
Oncogene; 2002 Jul; 21(31):4715-27. PubMed ID: 12101410
[TBL] [Abstract][Full Text] [Related]
10. p73alpha expression induces both accumulation and activation of wt-p53 independent of the p73alpha transcriptional activity.
Miro-Mur F; Meiller A; Haddada H; May E
Oncogene; 2003 Aug; 22(35):5451-6. PubMed ID: 12934105
[TBL] [Abstract][Full Text] [Related]
11. MDM2 and MDMX can interact differently with ARF and members of the p53 family.
Wang X; Arooz T; Siu WY; Chiu CH; Lau A; Yamashita K; Poon RY
FEBS Lett; 2001 Feb; 490(3):202-8. PubMed ID: 11223036
[TBL] [Abstract][Full Text] [Related]
12. Promoter specificity and stability control of the p53-related protein p73.
Lee CW; La Thangue NB
Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
[TBL] [Abstract][Full Text] [Related]
13. Expression profiles of p53, p63, and p73 in benign salivary gland tumors.
Weber A; Langhanki L; Schütz A; Gerstner A; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Nov; 441(5):428-36. PubMed ID: 12447671
[TBL] [Abstract][Full Text] [Related]
14. Subcellular distribution of p53 and p73 are differentially regulated by MDM2.
Gu J; Nie L; Kawai H; Yuan ZM
Cancer Res; 2001 Sep; 61(18):6703-7. PubMed ID: 11559539
[TBL] [Abstract][Full Text] [Related]
15. Identification of DeltaN isoform and polyadenylation site choice variants in molluscan p63/p73-like homologues.
Muttray AF; Cox RL; Reinisch CL; Baldwin SA
Mar Biotechnol (NY); 2007; 9(2):217-30. PubMed ID: 17242983
[TBL] [Abstract][Full Text] [Related]
16. p73 is not mutated in meningiomas as determined with a functional yeast assay but p73 expression increases with tumor grade.
Nozaki M; Tada M; Kashiwazaki H; Hamou MF; Diserens AC; Shinohe Y; Sawamura Y; Iwasaki Y; de Tribolet N; Hegi ME
Brain Pathol; 2001 Jul; 11(3):296-305. PubMed ID: 11414472
[TBL] [Abstract][Full Text] [Related]
17. Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.
Saifudeen Z; Diavolitsis V; Stefkova J; Dipp S; Fan H; El-Dahr SS
J Biol Chem; 2005 Jun; 280(24):23094-102. PubMed ID: 15805112
[TBL] [Abstract][Full Text] [Related]
18. Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas.
Takada N; Ozaki T; Ichimiya S; Todo S; Nakagawara A
Cancer Res; 1999 Jun; 59(12):2810-4. PubMed ID: 10383137
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of p73 and p53 regulation and effector functions.
Fang L; Lee SW; Aaronson SA
J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of cellular and viral promoters by p73 and p53.
Deb D; Lanyi A; Scian M; Keiger J; Brown DR; Le Roith D; Deb SP; Deb S
Int J Oncol; 2001 Feb; 18(2):401-9. PubMed ID: 11172610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
